Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Degeneration of Interpericyte Tunneling Nanotubes Can Occur in the Absence of Pericyte Loss in Diabetic Retina Disease.

Investigative ophthalmology & visual science·2026
Same author

Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy.

Survey of ophthalmology·2026
Same author

Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi study.

The British journal of ophthalmology·2026
Same author

Interpericyte tunnelling nanotube loss in very early diabetic retinal disease.

Diabetologia·2025
Same author

International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO).

American journal of ophthalmology·2025
Same author

Endothelial function can be modulated by acute hyperglycemia.

Scientific reports·2025

Related Experiment Video

Updated: Dec 30, 2025

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
09:24

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration

Published on: March 10, 2023

2.3K

CUTICULAR DRUSEN: Risk of Geographic Atrophy and Macular Neovascularization.

Yoichi Sakurada1,2,3, Ravi Parikh1,2, Orly Gal-Or1,2,4

  • 1LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, New York, New York.

Retina (Philadelphia, Pa.)
|January 24, 2020
PubMed
Summary

Cuticular drusen (CD) significantly increase the risk of developing geographic atrophy (GA) and macular neovascularization (MNV), particularly in specific phenotypes. Early detection and monitoring are crucial for managing this AMD-like progression.

More Related Videos

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.5K

Related Experiment Videos

Last Updated: Dec 30, 2025

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
09:24

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration

Published on: March 10, 2023

2.3K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.5K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Age-Related Macular Degeneration (AMD)

Background:

  • Cuticular drusen (CD) are associated with AMD manifestations like atrophy and neovascularization.
  • Understanding the progression risk of CD to AMD sequelae is critical for patient management.

Purpose of the Study:

  • To estimate the 5-year risk of progression from cuticular drusen (CD) to geographic atrophy (GA) and macular neovascularization (MNV).
  • To categorize CD into distinct phenotypes and assess their differential risk of progression.

Main Methods:

  • Longitudinal follow-up of eyes with CD, with retrospective analysis where possible.
  • Categorization of CD into three phenotypes based on distribution and association with large drusen.
  • Kaplan-Meier estimation used to calculate the 5-year incidence of GA and MNV.

Main Results:

  • Geographic atrophy developed in 19.0% of eyes, and MNV in 4.8%.
  • The estimated 5-year risk for GA and MNV was 28.4% and 8.7%, respectively.
  • Phenotypes 2 and 3 showed significantly higher 5-year incidence rates of GA or MNV (50.0% and 51.6%) compared to Phenotype 1 (12.6%).

Conclusions:

  • Phenotypes 2 and 3 of CD carry a significant risk of progression to GA or MNV.
  • CD, often diagnosed in the fifth decade with female predominance, may represent part of the AMD spectrum.
  • Multimodal imaging is essential for detecting CD and monitoring the risk of progression to GA and MNV.